Onze verantwoordelijkheid
Human Health Our Responsibility
Zoek op
5_feiten_over_diabetes_type_2_en_hart-_en_vaatziekten.pdf
5_manieren_om_je_kans_op_hart-_en_vaatziekten_te_verkleinen_als_je_diabetes_type_2_hebt.pdf
6_stappen_voor_een_fijner_leven_met_diabetes_type_2.pdf
boodschappentips_voor_mensen_met_diabetes_type_2.pdf
7_feiten_over_diabetes_type_2_0.pdf
7_feiten_over_diabetes_type_2-2.pdf
vul_deze_checklist_met_symptomen_van_diabetes_type_2_in.pdf
vul_deze_checklist_met_symptomen_van_diabetes_type_2_in-1.pdf
vul_deze_checklist_met_symptomen_van_diabetes_type_2_in-2.pdf
7_feiten_over_diabetes_type_2-3.pdf
tips_for_supporting_someone_living_with_type_2_diabetes_nl.pdf
7_feiten_over_diabetes_type_2_1.pdf
vul_deze_checklist_met_symptomen_van_diabetes_type_2_in_0.pdf
informatie_over_zes_belangrijke_complicaties_van_diabetes_type_2.pdf
vul_deze_zorgchecklist_in_en_probeer_je_kans_op_complicaties_van_diabetes_type_2_te_verkleinen.pdf
7_feiten_over_diabetes_type_2.pdf
Onze wetenschappelijke focus
Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19.
Preventie als sleutel tot gezonde longen
Preventie als sleutel tot gezonde longen
Obesitas
Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here.
Nieuw Europees consortium versnelt de ontwikkeling van behandelingen tegen COVID-19
Nieuw Europees consortium versnelt de ontwikkeling van behandelingen tegen COVID-19
Patiëntgerichtheid
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
ProZinc
Protamine Zinc
Pluimvee
We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs.
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim.